@unibiblio

Post-treatment de-phosphorylation of p53 correlates with dasatinib responsiveness in malignant melanoma

, , , , and . BMC Cell Biology, (2018)
DOI: 10.1186/s12860-018-0180-1

Links and resources

Tags